103 results
UPLOAD
VIRX
Viracta Therapeutics Inc
19 Jan 05
Letter from SEC
12:00am
manufacturer and single supplier
for
SNS-595 that you reference in subsequent risk factors, please
identify collaboration agreements upon which you … manufacturer and
single supplier for SNS-595 that you reference in subsequent risk
factors), please describe the material terms of your agreements
with
them
S-1/A
VIRX
Viracta Therapeutics Inc
27 Jan 05
IPO registration (amended)
12:00am
...," p. 11
"We rely on third parties to conduct our clinical trials...." p. 12
17. Other than the third party manufacturer and single supplier for SNS … for services, (other than the third party manufacturer and single supplier for SNS-595 that you reference in subsequent risk factors), please describe
424B5
VIRX
Viracta Therapeutics Inc
20 Jan 10
Prospectus supplement for primary offering
12:00am
and its active pharmaceutical ingredient, and depend on a single supplier for the active pharmaceutical ingredient. There are a limited number … is unable or unwilling to produce voreloxin, we will need to establish a contract with another supplier. However, establishing a relationship
8-K
EX-10.53
w71qma6k y7zy8vp
11 Dec 07
Entry into a Material Definitive Agreement
12:00am
10-Q
uag01izo ne3p
14 Nov 05
Quarterly report
12:00am
S-4/A
EX-10.25
jw1jrk3
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm